C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/18 (2006.01) C07K 14/21 (2006.01)
Patent
CA 2471115
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO:4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
L'invention concerne de nouvelles cibles m~dicamenteuses destin~es ~ des bact~ries pathognes. L'invention concerne par cons~quent une prot~ine purifi~e renfermant la s~quence d'acide amin~ pr~sent~e dans SEQ ID NO:4, ainsi que des caract~ristiques biochimiques et biophysiques des polypeptides selon l'invention.
Alam Muhammad Zahoor
Awrey Donald E.
Beattie Bryan
Dharamsi Akil
Domagala Megan
Affinium Pharmaceuticals Inc.
Alam Muhammad Zahoor
Awrey Donald E.
Beattie Bryan
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Peptidyl-trna hydrolase from pseudomonas aeruginosa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidyl-trna hydrolase from pseudomonas aeruginosa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidyl-trna hydrolase from pseudomonas aeruginosa will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1531439